You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
AstraZeneca
Colorcon
Mallinckrodt

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ATORVASTATIN CALCIUM

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

505(b)(2) Clinical Trials for Atorvastatin Calcium

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT01964326 Actual Use Trial of Atorvastatin Calcium 10 mg Completed Pfizer Phase 3 2013-10-01 The purpose of this actual use study is to simulate the over the counter use of atorvastatin calcium 10 mg.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Atorvastatin Calcium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00024531 Lipitor as a Treatment for Alzheimer's Disease Completed Pfizer Phase 2 2000-10-01 The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease.
NCT00024531 Lipitor as a Treatment for Alzheimer's Disease Completed Institute for the Study of Aging (ISOA) Phase 2 2000-10-01 The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease.
NCT00065806 Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Completed Laura Schanberg Phase 3 2003-09-01 The purpose of this study is: 1. To assess the efficacy of a lipid-lowering agent (atorvastatin) on the development of atherosclerosis that predisposes children with SLE to cardiovascular events in adulthood. 2. To assess the safety of intermediate-term (36 months) treatment of children and young adults with atorvastatin. 3. To further characterize the course of SLE in children and young adults, by establishing a cohort of pediatric SLE patients to be followed prospectively. 4. To establish a mechanism for conducting clinical trials in rare pediatric rheumatic diseases using the Children's Arthritis and Rheumatology Research Alliance (CARRA).
NCT00211939 CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients Completed Nabi Biopharmaceuticals Phase 4 2005-01-01 The purpose of the study is to evaluate the effects of two phosphate binders, PhosLo and sevelamer, on heart calcification in dialysis patients. The study will use a non-invasive technique, electron beam computed tomography (CT) scanning, to measure calcium in the coronary arteries, the aortic valve, and the mitral valve.
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. Completed Abbott Phase 3 2006-09-01 The primary purpose of this study is to test the safety and the effects of using an investigational drug regimen; once daily ABT-335 (Investigational drug) administered in combination with once daily atorvastatin calcium, rosuvastatin calcium or simvastatin in patients with abnormal lipid levels in the blood.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Atorvastatin Calcium

Condition Name

Condition Name for Atorvastatin Calcium
Intervention Trials
Healthy 10
Hypercholesterolemia 5
Mixed Dyslipidemia 3
Dyslipidemias 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Atorvastatin Calcium
Intervention Trials
Dyslipidemias 7
Hypercholesterolemia 5
Cardiovascular Diseases 4
Atherosclerosis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Atorvastatin Calcium

Trials by Country

Trials by Country for Atorvastatin Calcium
Location Trials
United States 32
China 11
India 4
Korea, Republic of 3
Germany 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Atorvastatin Calcium
Location Trials
Maryland 3
Illinois 3
Minnesota 3
California 2
North Dakota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Atorvastatin Calcium

Clinical Trial Phase

Clinical Trial Phase for Atorvastatin Calcium
Clinical Trial Phase Trials
Phase 4 9
Phase 3 9
Phase 2 9
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Atorvastatin Calcium
Clinical Trial Phase Trials
Completed 28
Not yet recruiting 7
Recruiting 6
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Atorvastatin Calcium

Sponsor Name

Sponsor Name for Atorvastatin Calcium
Sponsor Trials
Dr. Reddy's Laboratories Limited 6
Pfizer 5
Chong Kun Dang Pharmaceutical 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Atorvastatin Calcium
Sponsor Trials
Other 31
Industry 28
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
AstraZeneca
Johnson and Johnson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.